British Medical
Association Calls For Decriminalizing Medical Marijuana,
But Wallows in Reefer Madness
April 22, 1998The Independent, 1 Canada Square, Canary Wharf,
London E14 5DL England
letters@independent.co.uk
http://www.independent.co.uk/
By Colin Brown
(Ed. note: This demonstrates once again the full arrogance and
ignorance of organized medicine and our would be keepers in the therapeutic state. While
this report makes the Home Secretary look bad, it makes the BMA look even worse. One
expects narks to be narks, but when docs are both narks and quacks, this is a bit much.)
See
British
Medical Association and Government Graciously Allow Sick and Dying Synthetic
Cannabis In 2 Years, Maybe
UK:DONT PUNISH CANNABIS USERS SAYS BMA
The British Medical Association yesterday threw its weight behind MPs who have been
campaigning for cannabis to be legalised for therapeutic use by
urging the Home Secretary not to punish sufferers for taking the drug illegally.
A BMA team complained to a Lords committee investigating the scientific use of the drug
that the Home Office appeared to be dragging its heels in licensing trials for
developing drugs from cannabis. There had been no response to 14 requests for licenses,
the peers were told.
"If a patient is not suitable for trial, and there are no other alternatives
available, then we do believe they should be treated sympathetically in terms of the law
and any penalty where they are using herbal cannabis for their own therapeutic
benefit," Professor Vivienne Nathanson told the Lords committee on science and
technology.
Professor Nathanson, head of the BMAs professional resources and research group,
said she believed there could be a big worldwide demand for a cannabis-based
drug which could relieve some of the symptoms of muscular dystrophy, muscle spasms,
glaucoma, vomiting after chemotherapy and chronic pain.
"The numbers of patients who might benefit in a worldwide
context may be very considerable," she said.
(Ed. note: Of course, most of the people in the world
will not be able to afford these synthetics and no one should have to wait, which is sort
of more or less what the BMA is kind of like saying, maybe. In reality they
are pleading guilty to having suppressed a medicine that should never have been banned.
Moreover, Marihuana, the Forbidden Medicine
was published several years ago in Britain, so they cannot blame anyone for not telling
them.)
The committee is focusing on the scientific value of developing cannabis, which it
heard had fallen out of use after the Victorian era, when newer drugs became available.
The BMA team told the peers that once drugs were developed, it was likely they would be
administered in the future by use of inhalers.
But the BMA said smoking a cannabis joint could be five times
more carcinogenic than a tobacco cigarette. The BMA came down firmly against the
legalisation of cannabis for recreational use.
"Because of the way in which it is smoked, a single cannabis joint delivers the equivalent in carbon monoxide, irritants and carcinogens of 4-5 tobacco
cigarettes and carries similar cardiovascular and respiratory health risks including the
risk of lung cancer," said Professor Heather Ashton, Emeritus Professor of
Clinical Psychopharmacology.
(Ed. note: "The way in which it is smoked" is a
function of marijuana prohibition, not inherent in the plant. If these health risks were
real, they would then be iatrogenic, that is caused by the very doctors
who support the prohibition that causes the risk, which they then use to justify keeping
control over our bodies!)
Professor Ashton, who was the consultant writer for the BMA report, Therapeutic uses of
Cannabis, told the peers that her own students in Newcastle were
also reporting dependency on cannabis,
which was stronger now than 10 or 20 years ago.
The BMA is calling for research into developing synthetic forms of cannabis to avoid
the side effects - including getting high - in the use of the drug for
therapeutic use.
The health risks associated with smoking cannabis, including possible passive smoking
by the families of cannabis users, reinforced the BMAs case for new forms of the drug to
be developed.
But the team stressed that were were problems with developing
drugs which could avoid the side-effects associated with cannabis.
There were also
difficulties in establishing accurate tests for the drug, which had made it so far
impossible to develop a roadside test for drivers like the breath test for alcohol.